TGFB1 and neoplasm: The combination inhibited the TGF-β signaling pathway and collagen synthesis, significantly improving the TME, reducing tumor pressure, enhancing the penetration of the chemotherapeutic drug gemcitabine, and increasing the sensitivity of cancer cells to chemotherapy (Zhou et al., 2024).